267 related articles for article (PubMed ID: 28672024)
21. Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice.
Shi W; Ma H; Liu T; Yan D; Luo P; Zhai M; Tao J; Huo S; Guo J; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
J Cell Mol Med; 2020 Apr; 24(8):4748-4761. PubMed ID: 32164044
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
[TBL] [Abstract][Full Text] [Related]
23. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.
Ruwanpura SM; McLeod L; Miller A; Jones J; Vlahos R; Ramm G; Longano A; Bardin PG; Bozinovski S; Anderson GP; Jenkins BJ
Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(7):L627-39. PubMed ID: 22268122
[TBL] [Abstract][Full Text] [Related]
24. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
Chen W; Yuan H; Cao W; Wang T; Chen W; Yu H; Fu Y; Jiang B; Zhou H; Guo H; Zhao X
Theranostics; 2019; 9(14):3980-3991. PubMed ID: 31281526
[No Abstract] [Full Text] [Related]
25. Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition.
Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Go EJ; Hahm KB
Oncotarget; 2016 Feb; 7(7):7667-82. PubMed ID: 26716648
[TBL] [Abstract][Full Text] [Related]
26. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.
Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q
Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
[TBL] [Abstract][Full Text] [Related]
28. Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130.
Hayashi M; Rho MC; Enomoto A; Fukami A; Kim YP; Kikuchi Y; Sunazuka T; Hirose T; Komiyama K; Omura S
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14728-33. PubMed ID: 12417753
[TBL] [Abstract][Full Text] [Related]
29. Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer.
Fu S; Chen X; Lo HW; Lin J
Cancer Lett; 2019 Apr; 448():11-19. PubMed ID: 30707920
[TBL] [Abstract][Full Text] [Related]
30. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
[TBL] [Abstract][Full Text] [Related]
31. Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity.
Wu J; Guo W; Lin SZ; Wang ZJ; Kan JT; Chen SY; Zhu YZ
Cell Death Dis; 2016 Aug; 7(8):e2339. PubMed ID: 27537522
[TBL] [Abstract][Full Text] [Related]
32. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
[TBL] [Abstract][Full Text] [Related]
33. Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability.
Cousins E; Nicholas J
J Virol; 2013 Oct; 87(19):10816-27. PubMed ID: 23903842
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista.
Shi W; Yan D; Zhao C; Xiao M; Wang Y; Ma H; Liu T; Qin H; Zhang C; Li C; Lin J; Li S; Lv J; Lin L
Biochem Biophys Res Commun; 2017 Sep; 491(1):159-165. PubMed ID: 28711499
[TBL] [Abstract][Full Text] [Related]
35. Recombinant soluble gp130 protein reduces DEN-induced primary hepatocellular carcinoma in mice.
Hong J; Wang H; Shen G; Lin D; Lin Y; Ye N; Guo Y; Li Q; Ye N; Deng C; Meng C
Sci Rep; 2016 Apr; 6():24397. PubMed ID: 27080032
[TBL] [Abstract][Full Text] [Related]
36. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
Wei CC; Ball S; Lin L; Liu A; Fuchs JR; Li PK; Li C; Lin J
Int J Oncol; 2011 Jan; 38(1):279-85. PubMed ID: 21109950
[TBL] [Abstract][Full Text] [Related]
37. A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130.
Hong SS; Choi JH; Lee SY; Park YH; Park KY; Lee JY; Kim J; Gajulapati V; Goo JI; Singh S; Lee K; Kim YK; Im SH; Ahn SH; Rose-John S; Heo TH; Choi Y
J Immunol; 2015 Jul; 195(1):237-45. PubMed ID: 26026064
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
[TBL] [Abstract][Full Text] [Related]
39. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
[TBL] [Abstract][Full Text] [Related]
40. Breast Cancer-Derived Exosomes Alter Macrophage Polarization
Ham S; Lima LG; Chai EPZ; Muller A; Lobb RJ; Krumeich S; Wen SW; Wiegmans AP; Möller A
Front Immunol; 2018; 9():871. PubMed ID: 29867925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
